当社の戦略
持続可能性 + イノベーション = 成長
過去18か月間、当社はコンシューマーケアとライフサイエンスに特化した企業への移行を進めるため、当社戦略のカギとなる要素を加速させてきました。これらの市場にわたり、持続可能性にイノベーションを併せることが当社の将来の成長の原動力となると思われます。当社はお客様やサプライヤーと連携して活動し、「スマートサイエンスを活かして人々の生活向上に貢献する（Smart science to improve lives™）」を活用するという「当社のパーパス（存在目的）」を果たすための実行を重視しています。2021 Annual Report
10.3 MB
2023年 報告データパック
私たちの戦略：
Smart science to improve lives™
Sustainability
Innovation
Scale biotechnology
Scaling biotechnology is enabling ingredients to be produced using techniques such as fermentation, significantly improving the sustainability profile of manufacturing processes and raw materials.
Doing the basics brilliantly
Our 'doing the basics brilliantly' programme drives continuous operational improvements, aimed at improving the customer experience and increasing employee productivity by leveraging digital technologies and streamlining processes.
Strengthen to grow consumer care
In Consumer Care we aim to be the most sustainable, responsive supplier of innovative ingredients. We are strengthening the portfolio through continued innovation, developing claims-based ingredients with objective and verifiable performance data provided by our advanced validation techniques. The sustainability profile of our portfolio is a source of competitive advantage and we are further strengthening the portfolio by developing new ingredients with superior sustainability credentials, including bio-based, biodegradable and low-carbon products, with validated claims data.
Expand life sciences
Our strategy in Life Sciences is to empower biologics delivery, enabling the shift to biological active ingredients in pharmaceutical and agricultural markets that will drive structural growth opportunities in the years to come. This move from chemically synthesised to biological active ingredients is already underway in pharmaceutical markets but is in its earlier stages in agricultural markets. We aim to broaden our portfolio of pharma delivery systems and bioprocessing aids through organic investment, technology partnerships and selective bolt-on acquisitions that bring a unique capability to the Group.
Proactive M&A
We look to acquire disruptive technologies and complementary bolt-on acquisitions that we can scale through organic investment in line with our 'buy and build' model. M&A is strategy-led with 'chief scouts' in Consumer Care and Life Sciences working to identify technologies of the future.
Fast grow Asia
By expanding our presence in Asia, we will be able to access high-growth markets that are developing at a faster pace with opportunities across Consumer Care and Life Sciences.
事業内容
革新的で持続可能な成分の開発と提供は当社のビジネスの中心にあります。これらの成分は完成品のごく小さな割合に過ぎないこともしばしばですが、独自の性能によるメリットを実現することで違いを生み出すのがそうした部分なのです。